Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
AZD8055: Protocol Guidance for mTOR Pathway Inhibition
2026-06-09
AZD8055 is a potent, selective mTOR inhibitor optimized for dissecting mTORC1 and mTORC2 signaling in preclinical cancer and metabolic research models. It is intended for mechanistic studies rather than clinical efficacy endpoints. Researchers should follow precise solubilization and experimental workflows to ensure reproducibility and avoid common technical pitfalls.
-
Bsa I (RNase-free): Technical Guide for DNA Manipulation Wor
2026-06-09
Bsa I (RNase-free) addresses the need for precise DNA cleavage in molecular biology research, particularly where RNA integrity is critical. It is suitable for gene cloning, DNA manipulation, and recombinant DNA technology workflows, but should not be used in diagnostic or medical settings.
-
Cell Counting Kit-8 (CCK-8): Precision in Ferroptosis and Gl
2026-06-08
Explore how the Cell Counting Kit-8 (CCK-8) revolutionizes cell viability and cytotoxicity assays, with a unique focus on ferroptosis research and primary open-angle glaucoma. Uncover advanced insights not addressed in typical CCK-8 guides.
-
Next-Gen mRNA Delivery: Mechanisms, Strategies, and ARCA Cy5
2026-06-08
This article unites mechanistic insights and strategic perspectives on mRNA delivery, localization, and translation efficiency in mammalian cells. Anchored by the advanced features of ARCA Cy5 EGFP mRNA (5-moUTP), and contextualized within evolving nanoparticle delivery systems, it offers translational researchers a roadmap for rigorous, immune-evasive, and quantitative analysis—bridging state-of-the-art protocol guidance with vision for next-generation mRNA therapeutics.
-
High-Throughput Surrogate BBB Model for CNS Drug Screening
2026-06-07
This study introduces a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, incorporating lysosomal trapping correction to improve prediction of brain permeability. The validated platform streamlines early CNS drug candidate selection and enables more accurate assessment of passive diffusion, transporter-mediated efflux, and intracellular sequestration.
-
HBTU: Precision Peptide Bond Formation for Cancer-Selective
2026-06-06
HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) is pivotal for synthesizing advanced, enzyme-responsive peptide therapeutics with exceptional cancer selectivity. This article translates the latest research into actionable protocols, troubleshooting insights, and workflow strategies for leveraging HBTU in next-generation peptide synthesis.
-
Multiomics Dissection of Acute Liver Injury: Module-Based In
2026-06-05
This study pioneers a multiomics approach to map the molecular modules and regulatory networks underlying acute liver injury. By comparing the therapeutic mechanisms of bifendate and muaddil sapra, the work identifies key gene clusters, non-coding RNAs, and protein targets, offering new direction for targeted intervention and future research.
-
WP1066, JAK2/STAT3 Inhibitor: Applied Workflows in Oncology
2026-06-05
WP1066, a cell-permeable JAK2/STAT3 inhibitor from APExBIO, enables precision dissection of oncogenic and immunometabolic signaling in both cancer and regenerative research. This article delivers stepwise experimental guidance, advanced use-case insights, and troubleshooting strategies to maximize reproducibility and translational impact.
-
Reliable Affinity Purification with HyperTrap Heparin HP Col
2026-06-04
This article delivers scenario-driven, evidence-based guidance for biomedical researchers facing challenges in protein purification and signaling analysis. By focusing on the HyperTrap Heparin HP Column (SKU PC1009), it demonstrates how high-resolution, reproducible affinity chromatography can streamline workflows and enhance data reliability in cell viability and cancer research.
-
Eliminating Pollen Interference in Bioaerosol Spectral Analy
2026-06-04
This study introduces an advanced approach for removing pollen-induced spectral interference in the fluorescence-based classification of hazardous bioaerosols. By integrating spectral feature transformation and machine learning, the authors achieve high-accuracy identification of toxins and pathogens, with significant implications for rapid environmental monitoring and public health protection.
-
Bifendate (DDB): Mechanistic Leverage for Next-Gen Hepatopro
2026-06-03
This article delivers strategic guidance for translational researchers by integrating the latest mechanistic insights into Bifendate (DDB), a synthetic Schisandrin C derivative. It examines DDB’s role in hepatoprotection, lipid metabolism regulation, and autophagy inhibition, contextualized by competitive pharmacology and P450 modulation. The discussion bridges bench-to-bedside translation, grounded in robust evidence and practical protocol design, while highlighting APExBIO’s leadership in high-integrity research tools.
-
TK1 Expression in Uterine Corpus Endometrial Carcinoma: Insi
2026-06-03
This article reviews a recent comprehensive analysis of thymidine kinase 1 (TK1) in uterine corpus endometrial carcinoma (UCEC), highlighting the gene's upregulation, prognostic value, and its role in cell cycle and DNA replication. The findings support TK1 as a potential biomarker for diagnosis and therapy monitoring in UCEC, with implications for cell proliferation research.
-
Merimepodib (VX-497): Advanced Protocols for Antiviral Resea
2026-06-02
Merimepodib (VX-497) offers researchers a precision tool to dissect guanine nucleotide metabolism, serving as a powerful IMPDH inhibitor with broad applications in antiviral, immunosuppressive, and cancer research. This article translates cutting-edge findings into actionable protocols, workflow enhancements, and troubleshooting strategies that maximize the scientific impact of Merimepodib in the laboratory.
-
Sodium Picosulfate in GI Research: Protocols and Troubleshoo
2026-06-02
Sodium Picosulfate uniquely enables researchers to fine-tune water and electrolyte flux in gastrointestinal models, advancing both chronic and opioid-induced constipation studies. This guide translates recent neuroinflammation imaging breakthroughs into actionable workflows, troubleshooting, and cross-domain applications for gut–liver–brain axis research.
-
Corynoline Induces Mitochondrial Apoptosis via Src/JNK in Os
2026-06-01
The referenced study demonstrates that Corynoline, a natural isoquinoline alkaloid, exerts anti-osteosarcoma effects by inducing G2/M cell cycle arrest and promoting mitochondrial apoptosis through Src/JNK pathway activation. These findings highlight a promising mechanistic target for osteosarcoma treatment and inform future cell death analysis workflows.